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Abstract
The functional role of retrotrapezoid nucleus (RTN) neurons as the central 
chemoreceptors and the potential implications of Phox2b expressed in 
these neurons will be discussed. RTN resides at the ventral medullary sur-
face. RTN lesions reduce central respiratory chemoreception (CRC). RTN 
neurons are glutamatergic propriobulbar interneurons that selectively 
innervate the ventral respiratory column and other medullary regions 
essential to breathing. Their response to CO2 is presumably intrinsic. RTN 
neurons uniformly express Phox2b, a transcription factor whose mutation 
in man causes a loss of CRC and central sleep apnea. RTN neurons are 
activated by stimulation of the carotid bodies, restrained by inhibitory inputs 
from the central respiratory pattern generator and from lung afferents and 
their response to CO2 is sensitized by serotonin and by peptides released 
by serotonin neurons. The properties of RTN neurons are consistent with 
those expected from specialized central respiratory chemoreceptors. These 
data also suggest that respiratory reflexes operate in part by regulating 
the activity of central chemoreceptors. RTN neurons and the neurons that 
relay carotid body inputs to the respiratory centers express Phox2b. This 
peculiarity probably accounts for the loss of CRC associated with Phox2b 
mutations in man (central congenital hypoventilation syndrome). [Tzu Chi 
Med J 2008;20(4):239–242]
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1. Introduction
Central respiratory chemoreception (CRC) is the mech-
anism by which brain pCO2 regulates breathing. This 
mechanism is especially critical to sustain respiration 
during sleep. Brain pCO2 is almost certainly detected 
via changes in pH, but the molecular, cellular and in-
tegrative basis of CRC is still being defined [1]. Airway 
motor neurons and many of the neurons that make 
up the central respiratory pattern generating network 
(CPG) respond to acidification in various brainstem 
preparations in vitro [2,3]. Yet, in such preparations, 
even severe acidification only causes a weak activa-
tion of the oscillatory frequency of the respiratory net-
work and typically decreases rather than increases 
respiratory motor neuronal output. These results are in 
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striking contrast to the exquisite sensitivity of the res-
piratory outflow to pCO2 in vivo. One possible reason 
for this discrepancy is that CRC requires the partici-
pation of specialized pH-responsive neurons (central 
chemoreceptor neurons) and that the integrity of these 
cells or their connections to the CPG is disrupted in 
vitro. The existence of a genetic disease in humans 
in which CRC is selectively attenuated causing severe 
sleep apnea [4] strongly supports the existence of 
specialized central chemoreceptors.
The first experimental evidence suggesting the ex-
istence of specialized central chemoreceptors came 
from manipulations of the ventral medullary surface 
(VMS) (acidification, lesions) performed in the early 
1960s [5]. The VMS chemoreceptors have not been 
definitively identified and the literature suggests that 
other chemoreceptors may reside elsewhere in the 
ventrolateral medulla and in the raphe [6].
This brief review summarizes our recent work on a 
group of VMS neurons whose properties are consistent 
with a central respiratory chemoreceptor role. These 
neurons are located in the retrotrapezoid nucleus (RTN), 
a name originally coined by Smith et al [7] to describe 
a cluster of cells that innervate more caudal regions 
of the ventral respiratory column. The RTN resides 
approximately at the level of area M, a region of the 
ventral medullary surface already known for its high 
pH sensitivity [5,8].
2. Properties of RTN neurons in vivo
2.1. Sensitivity to hypercapnia and 
evidence of intrinsic sensitivity to 
CO2 in vivo
A unique combination of characteristics distinguishes 
RTN neurons from most if not all other respiratory 
neurons examined to date. Under anesthesia, RTN neu-
rons are silent at low levels of end-expiratory pCO2 
(threshold around arterial pH of 7.5), increasingly active 
as pCO2 is raised, reaching about 8–14 Hz at 10% 
end-expiratory pCO2, and their CO2 threshold is always 
lower than that of the respiratory network [9–11]. 
Also, especially in vagotomized animals, RTN neurons 
typically do not display an ON-OFF discharge pattern 
like classic CPG neurons, even at very high levels of 
pCO2 [10]. Third and perhaps most critical, the CO2 
sensitivity of RTN neurons in vivo is resistant to block-
ade of ionotropic glutamatergic receptors and to the 
administration of high doses of morphine, whereas 
such treatments silence most CPG neurons and/or 
render them insensitive to CO2 [9]. These observations 
indicate that the CO2 sensitivity of RTN neurons is not 
driven by the activity of the CPG and is unlikely to be 
caused by synaptic inputs from pH-sensitive neurons 
located elsewhere in the brain.
2.2. Feed-forward regulation of RTN 
neurons by the carotid bodies
RTN neurons are strongly activated by carotid chem-
oreceptor stimulation [11]. The pathway from the ca-
rotid bodies to RTN may involve only two neurons, 
namely the primary afferents innervating the carotid 
bodies and second-order glutamatergic neurons lo-
cated in the commissural portion of the solitary tract 
nucleus. In essence, RTN neurons have the properties 
of a chemosensory integrating center: their activity 
reflects both brain pH and the composition of the 
arterial blood (pCO2 and pO2).
2.3. Feedback regulation of RTN neurons by 
pulmonary afferents
A large proportion of RTN neurons are inhibited by lung 
inflation [12]. This inhibition is caused by activation of 
slowly-adapting pulmonary mechanoreceptors (SARs). 
The pathway from SARs to RTN may also be di-synaptic, 
consisting of the primary afferents and GABAergic pump 
cells (the second-order neurons) located in the inter-
stitial portion of the solitary tract nucleus. This finding 
indicates that the excitatory drive from central chem-
oreceptors (RTN) to the CPG can be downregulated 
by inputs from lung mechanoreceptors. This process 
may be viewed as a negative feedback that decreases 
the influence of central chemoreceptors under con-
ditions when breathing is already highly active due 
to other causes than a high pCO2.
2.4. Feedback regulation of RTN neurons by 
the CPG
In vagotomized rats, there is clear evidence that RTN 
neurons receive CPG-related inputs. These inputs seem 
predominantly inhibitory and are most likely respon-
sible for the saturation of the discharge of RTN neu-
rons and of the phrenic nerve that is observed at high 
levels of CO2 [10]. The feedback from the CPG, like 
that from lung mechanoreceptors, may serve to down-
regulate the CO2-dependent excitatory drive from RTN 
when the CPG is being vigorously activated by other 
inputs (hypothetically by pain, emotions and exercise).
2.5. Transmitters, structure and anatomical 
projections of RTN neurons
RTN neurons express the vesicular glutamate trans-
porter type-2, suggesting that they release glutamate 
and are therefore excitatory [9]. This fact is consistent 
with prior evidence that the RTN region is a source of 
excitatory drive to the CPG [11,13]. RTN neurons have 
 TZU CHI MED J  December 2008  Vol 20  No 4 241
two dendritic domains, one of which resides within 
the marginal layer of the ventral medulla [9,10]. RTN 
neurons should therefore be exceptionally respon-
sive to local application of drugs or acid at the VMS, 
consistent with the possibility that these neurons could 
be the VMS chemoreceptors identified earlier as area 
M [5,14].
Also consistent with a central chemoreceptor role, 
RTN neurons do not innervate the spinal cord but 
they do innervate the regions of the brainstem that 
contain the CPG, i.e., the ventral respiratory column, 
dorsolateral pons and selected lateral regions of the 
solitary tract nucleus [9,15,16].
2.6. Phox2b, RTN and the central congenital 
hypoventilation syndrome
Mutations of the homeobox gene PHOX2B are respon-
sible for most cases of central congenital hypoventi-
lation syndrome (CCHS) [4,17]. The cardinal symptoms 
of CCHS are a very severe central sleep apnea and a 
profound reduction of peripheral and central chem-
oreflexes [17–19]. A remarkable feature of the dis-
ease is that breathing is usually fairly normal during 
waking and responds normally to exercise and emo-
tions [20,21]. These characteristics suggest that the 
CPG of CCHS patients must be largely intact, hence 
the greatly reduced respiratory activity during sleep 
may be due to the selective loss of neurons implicated 
in CRC.
Consistent with this notion, Phox2b is expressed 
by an unbroken chain of neurons involved in the in-
tegration of peripheral and central chemoreception 
[22]. This circuit includes the carotid bodies, carotid 
body sensory afferents, and the NTS neurons that are 
activated by carotid body afferents and innervate the 
ventrolateral medulla and the RTN neurons themselves 
[11,22–24]. The prevalence of Phox2b in this circuit 
and its scarcity in regions involved in respiratory rhythm 
and pattern generation (ventral respiratory column 
caudal to RTN, cardiorespiratory regions of the dorsal 
pons) explains why PHOX2B mutations selectively 
impair the chemical drive to breathe and hence cause 
sleep apnea without major breathing disruption while 
awake.
3. Properties of RTN neurons in vitro 
and mechanisms of pH sensitivity
In slices (postnatal age P4 to P12), the RTN region con-
tains neurons that respond vigorously to acidification 
by increasing their discharge rate [9]. These neurons 
are located at the ventral surface of the medulla and 
they have the characteristic dendritic structure of the 
CO2-sensitive neurons that have been recorded in vivo 
[10]. The response of RTN neurons to CO2 in vitro 
is mediated by changes in pH [9]. It is temperature-
sensitive (Q10 ∼ 2.5) and robust (2.2 Hz per 0.1 pH unit 
at 37°C) [10]. In slices, RTN neurons discharge toni-
cally, regardless of the recording temperature [10]. 
Their pH sensitivity is independent of glutamatergic, 
GABAergic, glycinergic and purinergic transmission. 
The pH sensitivity of RTN neurons is therefore largely 
intrinsic [9,25], an interpretation that is consistent with 
the presence of a TTX-resistant pH-modulated resting 
potassium conductance in these cells [9]. This current 
has the properties of a leak current but the responsible 
channel, still unidentified, is not TASK (Twik-related 
acid-sensitive potassium channel). The pH-sensitive 
neurons that we study in vitro are almost certainly the 
same as those that we record in vivo because they 
have the same location and structure and they contain 
Phox2b mRNA as revealed by single cell polymerase 
chain reaction.
4. Conclusions
RTN neurons have numerous structural and physio-
logical characteristics that are consistent with a cen-
tral chemoreceptor role. RTN neurons are located at 
the VMS, their sensitivity to pH is high and independent 
of the activity of the rest of the respiratory network. 
RTN neurons release an excitatory transmitter (gluta-
mate), their CO2 threshold is below that at which the 
CPG is activated, and they have selective projections to 
the brainstem regions that contain the CPG. Consistent 
with the notion that their pH sensitivity is intrinsic, 
RTN neurons express a pH-sensitive background po-
tassium conductance. Finally, RTN neurons in rodents 
also express a developmental gene (Phox2b) which, 
when mutated, is associated with a dramatic and 
selective loss of central respiratory chemosensitivity 
in man [4].
This checklist is compelling, but it does not consti-
tute proof that the Phox2b-expressing neurons of RTN 
are critical to CRC nor that these neurons are the only 
central respiratory chemoreceptors. Such proof would 
require demonstrating that their selective destruction 
eliminates or, at least, attenuates the response of the 
respiratory network to hypercapnia. This goal has not 
been achieved yet but lesions of the region where 
these chemosensitive cells are located have produced 
results that are consistent with this notion [26].
Finally, if one accepts the interpretation that RTN 
neurons are central chemoreceptors, this type of cell 
should not be viewed as solely regulated by pH. Clearly, 
at any given brain pH, the firing rate of RTN neurons 
can also be greatly modified by lung inflation (via 
mechanoreceptors), blood gases (via the carotid bod-
ies), the degree of activation of the CPG and, most 
likely, by a host of inputs still to be discovered.
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